Literature DB >> 4045430

Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development.

H Caplen, C J Peters, D H Bishop.   

Abstract

Serial mutagenesis with 5-fluorouracil has been employed to derive an attenuated strain of Rift Valley fever virus for use as a live virus vaccine.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4045430     DOI： 10.1099/0022-1317-66-10-2271

Source DB:  PubMed          Journal:  J Gen Virol        ISSN： 0022-1317            Impact factor:   3.891


  116 in total

1.  The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice.

Authors:  P Vialat; A Billecocq; A Kohl; M Bouloy
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds.

Authors:  S Garcia; J M Crance; A Billecocq; A Peinnequin; A Jouan; M Bouloy; D Garin
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

Review 3.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

4.  Identification of Rift Valley fever virus nucleocapsid protein-RNA binding inhibitors using a high-throughput screening assay.

Authors:  Mary Ellenbecker; Jean-Marc Lanchy; J Stephen Lodmell
Journal:  J Biomol Screen       Date:  2012-05-29

5.  Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves.

Authors:  John C Morrill; Richard C Laughlin; Nandadeva Lokugamage; Jing Wu; Roberta Pugh; Pooja Kanani; L Garry Adams; Shinji Makino; C J Peters
Journal:  Vaccine       Date:  2013-08-27       Impact factor: 3.641

6.  Genetic subpopulations of Rift Valley fever virus strains ZH548 and MP-12 and recombinant MP-12 strains.

Authors:  Nandadeva Lokugamage; Alexander N Freiberg; John C Morrill; Tetsuro Ikegami
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

7.  Novel Ionophores Active against La Crosse Virus Identified through Rapid Antiviral Screening.

Authors:  Zachary J Sandler; Mason R Firpo; Oreoluwa S Omoba; Michelle N Vu; Vineet D Menachery; Bryan C Mounce
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

8.  Toscana virus NSs protein promotes degradation of double-stranded RNA-dependent protein kinase.

Authors:  Birte Kalveram; Tetsuro Ikegami
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

9.  Impact of Protein Glycosylation on the Design of Viral Vaccines.

Authors:  Kathleen Schön; Bernd Lepenies; Guillaume Goyette-Desjardins
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

10.  A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity.

Authors:  David H Holman; Adam Penn-Nicholson; Danher Wang; Jan Woraratanadharm; Mary-Katherine Harr; Min Luo; Ellen M Maher; Michael R Holbrook; John Y Dong
Journal:  Clin Vaccine Immunol       Date:  2009-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.